(Q39652042)
English
Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group
scientific article published on 14 February 2012
Statements
1 reference
Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (English)
1 reference
1 reference
Jacques Grill
1 reference
John-Paul Kilday
1 reference
Biswaroop Mitra
1 reference
Caroline Domerg
1 reference
Teresa Osteso-Ibanez
1 reference
Marie-Cecile Le Deley
1 reference
David W Ellison
1 reference
Richard J Gilbertson
1 reference
Richard G Grundy
1 reference
14 February 2012
1 reference
1 reference
Identifiers
1 reference